Results 11 to 20 of about 2,332,624 (263)

Cadre d'indicateurs des maladies chroniques et des blessures - Statistiques rapides, édition 2016

open access: yesPromotion de la santé et prévention des maladies chroniques au Canada, 2016
null
Centre de prévention des maladies chroniques
doaj   +1 more source

Cadre d'indicateurs de surveillance de la santé mentale positive : Statistiques rapides, adultes (18 ans et plus), Canada, édition 2016

open access: yesPromotion de la santé et prévention des maladies chroniques au Canada, 2016
null
Centre de prévention des maladies chroniques
doaj   +1 more source

HIV treatment as prevention: models, data, and questions--towards evidence-based decision-making.

open access: yesPLoS Medicine, 2012
Antiretroviral therapy (ART) for those infected with HIV can prevent onward transmission of infection, but biological efficacy alone is not enough to guide policy decisions about the role of ART in reducing HIV incidence.
HIV Modelling Consortium Treatment as Prevention Editorial Writing Group
doaj   +1 more source

Chinese Diabetes Behavior and Lifestyle Intervention Guidelines (2024) [PDF]

open access: yesZhongguo quanke yixue
Behavior and lifestyle interventions (BLIs) can reduce blood glucose and blood pressure, regulate blood lipids, control obesity, reduce cardiovas cular events and are a first-line treatment for chronic diseases such as diabetes mellitus.
Diabetes Prevention and Control Committee of Chinese Preventive Medicine Association
doaj   +1 more source

Erratum

open access: yesHealth Promotion and Chronic Disease Prevention in Canada, 2017
Correction to: CCDI Steering Committee. At-a-glance – The 2017 Canadian Chronic Disease Indicators. Health Promot Chronic Dis Prev Can. 2017;37(8):248-51.
Health Promotion and Chronic Disease Prevention in Canada editorial team
doaj   +1 more source

Allergy prevention [PDF]

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2009
SummaryThe further increase of allergies in industrialized countries demands evidence‐based measures of primary prevention. The recommendations as published in the guideline of 2004 were updated and consented on the basis of a systematic literature search. Evidence from the period February 2003–May 2008 was searched in the electronic databases Cochrane
Muche-Borowski, Cathleen   +5 more
openaire   +5 more sources

Sustained Therapeutic Efficacy of Intravenous Plasminogen Concentrate in Pediatric Patients With Type 1 Plasminogen Deficiency: An Analysis of Dosing Parameters and Clinical Outcomes

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Type 1 plasminogen deficiency (PLGD‐1) is an ultra‐rare autosomal recessive disorder caused by variants in the PLG gene and affects approximately 1.6 individuals per million. The condition is characterized by decreased plasminogen levels and impaired function, resulting in fibrin‐rich lesions on mucous membranes throughout the body.
Charles Nakar   +7 more
wiley   +1 more source

The European Union One Health 2020 Zoonoses Report

open access: yesEFSA Journal, 2021
This report of the EFSA and the European Centre for Disease Prevention and Control presents the results of zoonoses monitoring activities carried out in 2020 in 27 EU Member States (MS) and nine non‐MS.
European Food Safety Authority   +1 more
doaj   +1 more source

Guidelines for Pediatric Radiotherapy Simulation: A Report From the Children's Oncology Group Radiation Oncology Discipline

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric radiation therapy presents unique challenges compared to adult treatments, including those of immobilization, potential need for sedation, and the critical importance of accurate, reproducible positioning. Additionally, heightened attention to imaging doses is necessary to minimize long‐term toxicity in survivors.
Parham Alaei   +17 more
wiley   +1 more source

Chronic Disease and Injury Indicator Framework: Quick Stats, 2015 Edition

open access: yesHealth Promotion and Chronic Disease Prevention in Canada, 2015
null
Centre for Chronic Disease Prevention, Public Health Agency of Canada
doaj   +1 more source

Home - About - Disclaimer - Privacy